OneBlood is the first blood center to get full FDA approval to give high-titer COVID-19 convalescent plasma to those with COVID-19 who are also immunocompromised.
Spravato is now the first stand-alone therapy for treatment-resistant depression, for patients who haven't responded to oral ...
The U.S. Food and Drug Administration ( FDA) has approved the use of a nasal spray as a standalone treatment for major depressive disorder, offering a new option for those struggling with ...
Johnson & Johnson has announced the FDA’s approval ... Spravato has since been approved in 77 countries and prescribed to over 140,000 patients. As of Tuesday, the US is now also one of those ...
The Food and Drug Administration (FDA) approved Johnson & Johnson's ketamine ... "dissociative drug" – to combat depression. It also made headlines due to its use by high-profile figures ...
Federal regulators have warned a Waco company that its human amniotic products are “unlicensed” and “unapproved,” and that ...
The companies said their products will meet the IRA domestic content threshold. Image: Terrasmart. Solar racking provider TerraSmart and thin-film Cadmium Telluride (CdTe) solar manufacturer First ...
The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used as a standalone treatment for patients with severe depression ...
Police in Columbia, South Carolina, are investigating a "suspicious death" after a missing 13-year-old girl was found dead in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback